Indeed, studies show that EGFR-mutated adenocarcinomas that harbor RB1 and TP53 alterations at baseline are uniquely predisposed to transformation, as virtually all transformed tumors have these mutations prior to therapy81. Here, EGFR is linked to adenocarcinoma.